Biohaven Pharmaceutical Holding Company Ltd.
Utility Patent Applications
Last updated:
List of all Biohaven Pharmaceutical Holding Company Ltd. patents 12 in total
| Status | Patent |
|---|---|
Application | Utility: FORMULATION FOR ORAL DELIVERY OF PROTEINS, PEPTIDES AND SMALL MOLECULES WITH POOR PERMEABILITY Filling date: 7 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: USE OF RILUZOLE ORAL DISINTIGRATING TABLETS FOR TREATING DISEASES Filling date: 7 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: PRODRUGS OF CGRP ANTAGONISTS Filling date: 7 Sep 2025 Issue date: 23 Dec 2021 |
Application | Utility: CGRP ANTAGONISTS FOR TREATING MIGRAINE BREAKTHROUGH Filling date: 7 Sep 2025 Issue date: 4 Nov 2021 |
Application | Utility: CGRP ANTAGONISTS FOR TREATING MIGRAINE BREAKTHROUGH Filling date: 7 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE Filling date: 7 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: USE OF RILUZOLE PRODRUGS TO TREAT ATAXIAS Filling date: 7 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: RIMEGEPANT FOR CGRP RELATED DISORDERS Filling date: 7 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: RIMEGEPANT FOR CGRP RELATED DISORDERS Filling date: 7 Sep 2025 Issue date: 10 Dec 2020 |
Application | Utility: PRODRUGS OF LANICEMINE AND THEIR METHOD OF USE Filling date: 7 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE Filling date: 7 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: USE OF RILUZOLE, RILUZOLE PRODRUGS OR RILUZOLE ANALOGS WITH IMMUNOTHERAPIES TO TREAT CANCERS Filling date: 7 Sep 2025 Issue date: 26 Sep 2019 |
Showing 1 to 12 of 12 patents.